CD19 Is a Useful B Cell Marker After Treatment With Rituximab: Comment on the Article by Jones et al

Find Full text
Publication year
2013
Author(s)
Kamburova, E.G.
Koenen, H.J.P.M.
Joosten, I.
Hilbrands, L.B.
Source
Arthritis and Rheumatism, 65, 4, (2013), pp. 1130-1
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/118086   https://hdl.handle.net/2066/118086
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.